CMHC Masterclass On Demand: Frontiers in Interventional Cardiology

This masterclass is designed to explore the latest advances about the most pertinent domains in interventional cardiology. Multidisciplinary experts will present on comprehensive interventional cardiology topics, including pre-procedural evaluation, pharmacological aspects, coronary intervention, peripheral intervention, structural intervention, and more. Each section will include patient cases and expert panel discussion, which will aim to provide practical approaches to patient management and interpret the latest advances to patient care.

Target Audience

US-based healthcare professionals, including primary care clinicians (PCPs), interventional cardiologists, cardiologists, registered nurses, advanced practice registered nurses, dieticians, pharmacists, and other allied health professionals.

Learning Objectives

After completing this activity, the participant should be better able to:

  • Integrate advances in the screening, diagnosis, and risk assessment for patients with stable coronary and peripheral artery disease, as well those with acute coronary syndrome
  • Outline appropriate pharmacotherapy for patients ACS, CAD, and PAD before and after procedural interventions
  • Interpret the results from key clinical trials and evidence for patients with structural and valvular heart disease 
  • Evaluate the role of pharmacotherapy and evidence-based interventional technologies for the management of atrial fibrillation and arrhythmias
  • Discuss advances in pharmacotherapy and endovascular thrombectomy for stroke prevention inpatients with arrhythmias or VTE
  • Develop individualized treatment options and interventions for patients with CAD, PAD, ACS, arrhythmias, VTE, and structural/valvular heart disease that incorporate the latest advances in interventional technologies, drugs, and procedures to optimize outcomes
Course summary
Available credit: 
  • 10.00 ACPE Pharmacy
  • 10.00 AMA PRA Category 1 Credit
  • 10.00 ANCC
  • 10.00 CDE
  • 10.00 Participation
Course opens: 
Course expires: 
Deepak L. Bhatt, MD, MPH (Chair)
Professor of Medicine, Harvard Medical School
Executive Director of Interventional Cardiovascular Programs
Brigham and Women's Hospital Heart and Vascular Center
Boston, MA
Angela Lowenstern, MD, MHSc
Assistant Professor of Medicine
Interventional Cardiology
Vanderbilt University Medical Center
Nashville, TN

C. Michael Gibson, MS, MD
Interventional Cardiologist, Cardiovascular Researcher & Educator CEO, Baim and PERFUSE Research Institutes
Harvard Medical School
Boston, MA

Christine M. Albert, MD, MPH
Professor and Chair of the Department of Cardiology
Lee and Harold Kapelovitz Distinguished Chair in Cardiology at Cedars-Sinai Medical Center
Los Angeles, CA

Dominick J. Angiolillo, MD
Professor of Medicine with Tenure
Chief of Cardiology
Medical Director, UF Health Cardiovascular Center
Director, Cardiovascular Research
Program Director, Interventional Cardiology Fellowship
University of Florida College of Medicine
Jacksonville, Florida
Elaine M. Hylek, MD
Professor of Medicine
Boston University School of Medicine
Boston, MA

Geoffrey Barnes, MD
Assistant Professor, University of Michigan
Ann Arbor, MI

Gilbert H. Tang, MD
Associate Professor of Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai
Surgical Director, Structural Heart Program, Mount Sinai Health System
New York, NY
Gregory Piazza, MD
Associate Professor of Medicine, Harvard Medical School
Physician, Brigham and Women's Hospital
Boston, MA
Manesh R. Patel, MD
Chief, Division of Clinical Pharmacology
Chief, Division of Cardiology
Core Faculty in Innovation & Entrepreneurship
Duke University Medical Center
Durham, NC
Marc P. Bonaca, MD
Director of Vascular Research
Associate Professor of Medicine
University of Colorado School of Medicine
Aurora, CO
Mina Chung, MD
Professor of Medicine
Cardiac Pacing and Electrophysiology
Department of Cardiovascular Medicine, Heart and Vascular Institute
Department of Cardiovascular & Metabolic Sciences, Lerner Research Institute
Cleveland Clinic
Cleveland, OH
Peter H. Stone MD
Associate Professor of Medicine
Harvard Medical School
Co-Director, Samuel A. Levine Cardiac Unit
Director, Clinical Trials Center
Brigham and Women's Hospital
Rebecca T. Hahn MD
Professor of Medicine, Columbia University
Director of Interventional Echocardiography
The New York Presbyterian Hospital
New York, NY
Shamir R. Mehta MD
Douglas Holder PHRI Endowed Chair in Interventional Cardiology
Professor of Medicine
McMaster University
Director, Interventional Cardiology
Hamilton Health Sciences
Senior Scientist
Population Health Research Institute
Hamilton, Canada
Sonia Anand, MD
Professor of Medicine and Epidemiology
McMaster University
Hamilton, Ontario, Canada
Sripal Bangalore, MD
Professor, Department of Medicine at NYU Grossman School of Medicine 
Director of Research, Cardiac Catheterization Lab
Director, Cardiac Catheterization Laboratory, Bellevue Hospital
New York, NY
Tracy Y. Wang, MD
Associate Professor
Director, Health Services Research
Duke University
Durham, NC
William E. Boden, MD
Boston University School of Medicine
Dept of Medicine
Cardiovascular Medicine
Andrew Cluckey, MD
Interventional Cardiology Fellow
Vanderbilt University Medical Center
Nashville, TN
Kyle R. Lehenbauer, MD
Columbia University

10 hours

This activity is supported in part by an educational grant from Medtronic.



In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Tarsus Cardio Inc. dba Cardiometabolic Health Congress (CMHC). Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 10 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

Postgraduate Institute for Medicine designates this continuing education activity for 10 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education.

This is a knowledge-based activity. Universal Activity Numbers (UAN): JA4008162-9999-22-089-H01-P

For Pharmacists: Upon completion of the online evaluation, your credit will be submitted to CPE Monitor within 4-6 weeks. Pharmacists have up to thirty (30) days from the live event to complete the evaluation and claim credit.

The maximum number of hours awarded for this Continuing Nursing Education activity is 10 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.

This program offers 10 CPEUs for dieticians.

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

A full listing of faculty disclosures PDF icon can be downloaded here.

Planners and Managers
The PIM planners and managers have nothing to disclose. The CMHC planners and managers have nothing to disclose.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

There are no registration fees for this activity. During the period March 2, 2022 through March 2, 2023, participants must read the learning objectives and faculty disclosures, study the educational activity, and complete the evaluation. Upon completing, your certificate will be available for print. For questions about receiving certificates, please contact us at

For questions about the accreditation of this activity, please visit

For Pharmacists: Please complete the evaluation instructions above. Upon registering and completing the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service within 4-6 weeks.

Available Credit

  • 10.00 ACPE Pharmacy
  • 10.00 AMA PRA Category 1 Credit
  • 10.00 ANCC
  • 10.00 CDE
  • 10.00 Participation
Please login or register to take this course.

There are no registration fees for this activity. Please enroll and proceed with the course instructions.

Required Hardware/software

A computer with an internet connection

Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser

Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.